Canada Pension Plan Investment Board’s Sagimet Biosciences SGMT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.3K	Buy	+12,500	New	+$69.7K	﹤0.01%	1667

Other funds holding SGMT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Canada Pension Plan Investment Board's SGMT Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Sagimet Biosciences (SGMT) in Q1 2026: 12,500 shares worth $65.3K. The stake represents ﹤0.01% of the portfolio and ranks #1667 among its holdings.

88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

Canada Pension Plan Investment Board held 12,500 shares of Sagimet Biosciences worth $65.3K as of Q1 2026.
Sagimet Biosciences was a new Canada Pension Plan Investment Board position in Q1 2026.
Sagimet Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1667 holding.
88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.